Merck Receives FDA Breakthrough Therapy Designation for KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer

… and histology, including exploring different tumor characteristics such as PD-L1 expression … of lung cancer than die of colon, breast, and prostate cancers combined. The two main types of lung cancer are non …